Journal targeted by paper mill still grappling with the aftermath years laterDespite claims of addressing the issue, Bioengineered still contains hundreds of dubious papers linked to paper mills.
The next era of psychedelics may be precision-designed states of consciousnessMindstate Design Labs aims to create predictable psychedelic experiences for improved mental health treatment.
Four ways to power-up AI for drug discoveryAI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.
These 10 biotech companies are changing how we discover new drugs and treat complex diseasesBiotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.
Are Human Neurons AI's Future?The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.
Why tomorrow's breakthroughs will come from polyintelligent thinkingThe convergence of human, machine, and nature's intelligence offers unprecedented solutions to global challenges.
Rising stars in AI use robotics and automation to accelerate their workAI serves as a powerful tool to enhance scientific research rather than replace scientists.
Scientists use AI to design life-like enzymes from scratchAI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.
Four ways to power-up AI for drug discoveryAI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.
These 10 biotech companies are changing how we discover new drugs and treat complex diseasesBiotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.
Are Human Neurons AI's Future?The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.
Why tomorrow's breakthroughs will come from polyintelligent thinkingThe convergence of human, machine, and nature's intelligence offers unprecedented solutions to global challenges.
Rising stars in AI use robotics and automation to accelerate their workAI serves as a powerful tool to enhance scientific research rather than replace scientists.
Scientists use AI to design life-like enzymes from scratchAI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.
It's time to hit the reset button on GMOsGMO 2.0 is set to revolutionize agriculture with innovative technologies aiding sustainability and efficiency, addressing global food demand.
A cell pulls off one of the 'Holy Grails' of biotechnologyA groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.
Strong, flexible 'nylon' made by engineered bacteria for the first timeResearchers have created genetically engineered microbes that produce nylon-like plastics, offering a potential solution to plastic waste.
In other news this week: ZeroNorth secures 48.1M+, and moreA range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.
Green Innovation in Brazil: How Patent Protection Is Powering Sustainable AgricultureBrazil is poised to lead in agricultural biological agents due to its biodiversity and climate.
In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon CanalsStartups in sectors like agritech and biotech are securing significant funding to innovate and enhance sustainability in their respective industries.
It's time to hit the reset button on GMOsGMO 2.0 is set to revolutionize agriculture with innovative technologies aiding sustainability and efficiency, addressing global food demand.
A cell pulls off one of the 'Holy Grails' of biotechnologyA groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.
Strong, flexible 'nylon' made by engineered bacteria for the first timeResearchers have created genetically engineered microbes that produce nylon-like plastics, offering a potential solution to plastic waste.
In other news this week: ZeroNorth secures 48.1M+, and moreA range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.
Green Innovation in Brazil: How Patent Protection Is Powering Sustainable AgricultureBrazil is poised to lead in agricultural biological agents due to its biodiversity and climate.
In other news this week: Utrecht's Happybase bags 650K, Themis secures 8.7M to combat financial crime, SNIPR Biome gets 20M from EIB and more - Silicon CanalsStartups in sectors like agritech and biotech are securing significant funding to innovate and enhance sustainability in their respective industries.
FDA-Approved Artificial Blood Vessel Stirs ConcernsFDA approved Humacyte's lab-grown blood vessels despite serious patient complications, raising concerns about study validation and patient safety.
For Patients Needing Transplants, Hope Arrives on Tiny HoovesCloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.
Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseasesColossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.
Have Scientists Created Hybrids of Mice and Mammoths?Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.
Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
Scientists aiming to bring back woolly mammoth create woolly miceScientists create genetically modified woolly mice as a step toward reviving woolly mammoths.
These scientists are trying to revive woolly mammoths ... by modifying miceColossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.
Meet the 'woolly mouse': why scientists doubt it's a big step towards recreating mammothsColossal Biosciences announces breakthrough with genetic manipulation of mice, aimed at de-extincting woolly mammoths.
Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseasesColossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.
Have Scientists Created Hybrids of Mice and Mammoths?Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.
Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
Scientists aiming to bring back woolly mammoth create woolly miceScientists create genetically modified woolly mice as a step toward reviving woolly mammoths.
These scientists are trying to revive woolly mammoths ... by modifying miceColossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.
Meet the 'woolly mouse': why scientists doubt it's a big step towards recreating mammothsColossal Biosciences announces breakthrough with genetic manipulation of mice, aimed at de-extincting woolly mammoths.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity NewsBluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.
This Blood Vessel Was Grown in a Lab With Real Human CellsHumacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.
FDA approves siRNA drug for haemophilia prophylaxisFitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.
Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hungerSoleno Therapeutics' Vykat XR receives FDA approval for treating insatiable hunger linked to Prader-Willi syndrome, boosting stock significantly.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity NewsBluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.
This Blood Vessel Was Grown in a Lab With Real Human CellsHumacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.
FDA approves siRNA drug for haemophilia prophylaxisFitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.
Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hungerSoleno Therapeutics' Vykat XR receives FDA approval for treating insatiable hunger linked to Prader-Willi syndrome, boosting stock significantly.
23andMe thought its DNA data would help research. Then reality hit.23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.
Genetic data sharing service openSNP to close downOpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.
23andMe Is Selling All Your Data, in Largest Sale of Genomes in History23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.
23andMe thought its DNA data would help research. Then reality hit.23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.
Genetic data sharing service openSNP to close downOpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.
23andMe Is Selling All Your Data, in Largest Sale of Genomes in History23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.
Strong IP Protections are the Key to Growing U.S. ManufacturingStrengthening IP protections ensures that future products are not just designed but also manufactured in America.
Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry RequirementsThe Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.
Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.
Strong IP Protections are the Key to Growing U.S. ManufacturingStrengthening IP protections ensures that future products are not just designed but also manufactured in America.
Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry RequirementsThe Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.
Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.
'Startup Nation' Groups Say They're Meeting Trump Officials to Push for Deregulated 'Freedom Cities'Regulatory challenges hinder technological development despite available capital and political support.
Tech firms are cashing in on the bizarre science of organ preservationThe evolution of organ transplantation technology is creating new business opportunities.OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.
Emilia Tikka Studio Visit | Berlin Art LinkEmilia Tikka explores the intersection of cultural history and biotechnology, addressing societal implications through her art and research.
Cambridge company is laying of 180 people, 65% of its workforceEditas Medicine is laying off 65% of its workforce to focus on in vivo gene editing.
Tech firms are cashing in on the bizarre science of organ preservationThe evolution of organ transplantation technology is creating new business opportunities.OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.
Emilia Tikka Studio Visit | Berlin Art LinkEmilia Tikka explores the intersection of cultural history and biotechnology, addressing societal implications through her art and research.
Cambridge company is laying of 180 people, 65% of its workforceEditas Medicine is laying off 65% of its workforce to focus on in vivo gene editing.
The Billionaire Baker Brothers Just Made This Big Biotech Stock MoveBillionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.
Prediction: This Pharma Stock Will Be the Best Performer in 2025Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.
The Billionaire Baker Brothers Just Made This Big Biotech Stock MoveBillionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.
Prediction: This Pharma Stock Will Be the Best Performer in 2025Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.
Harvard startup creating a new class of antibiotics - Harvard GazetteKinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.
Bacterial 'jumping genes' can target and control chromosome ends | Cornell ChronicleTransposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.
Harvard startup creating a new class of antibiotics - Harvard GazetteKinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.
Bacterial 'jumping genes' can target and control chromosome ends | Cornell ChronicleTransposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.
Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.
National Growth Fund invests 1.4M in seven Twente-based biotech projectsSeven biotechnology projects from Twente received €1.4M funding, highlighting regional innovation and leadership in biotechnology.
French firm Bioptimus bags 74M - Silicon CanalsBioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.
Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon CanalsAugustine Therapeutics raises €77.7M for CMT disease treatment, marking a significant step in innovative therapeutics for neurodegenerative conditions.
Amsterdam's Leyden Labs secures 68M funding - Silicon CanalsLeyden Labs raised $70M to develop nasal spray solutions for respiratory virus protection, including leading-edge monoclonal antibodies.
Dutch biotech firm Citryll secures 85M funding - Silicon CanalsCitryll has raised €85M in Series B funding for its innovative therapy targeting Neutrophil Extracellular Traps (NETs) in inflammatory diseases.
Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.
National Growth Fund invests 1.4M in seven Twente-based biotech projectsSeven biotechnology projects from Twente received €1.4M funding, highlighting regional innovation and leadership in biotechnology.
French firm Bioptimus bags 74M - Silicon CanalsBioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.
Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon CanalsAugustine Therapeutics raises €77.7M for CMT disease treatment, marking a significant step in innovative therapeutics for neurodegenerative conditions.
Amsterdam's Leyden Labs secures 68M funding - Silicon CanalsLeyden Labs raised $70M to develop nasal spray solutions for respiratory virus protection, including leading-edge monoclonal antibodies.
Dutch biotech firm Citryll secures 85M funding - Silicon CanalsCitryll has raised €85M in Series B funding for its innovative therapy targeting Neutrophil Extracellular Traps (NETs) in inflammatory diseases.
A startup plans to make money from reviving the woolly mammoth. Here's how.Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.
UK's Epoch Biodesign secures 17.1M in Series AEpoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.
Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longerTech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.
In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon CanalsRecent tech funding stories highlight significant investments in AI, renewable energy, biotech, and electric vehicle infrastructure across Europe.
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunchOpenAI's CEO Sam Altman is heavily investing in biotech to extend human lifespan through disease-targeted drug development.
Leiden-based BIMINI Biotech bags 3MBIMINI Biotech secured €3M to develop cancer therapeutics targeting WASp, addressing high relapse rates and poor outcomes in hematological cancers.
A startup plans to make money from reviving the woolly mammoth. Here's how.Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.
UK's Epoch Biodesign secures 17.1M in Series AEpoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.
Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longerTech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.
In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon CanalsRecent tech funding stories highlight significant investments in AI, renewable energy, biotech, and electric vehicle infrastructure across Europe.
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunchOpenAI's CEO Sam Altman is heavily investing in biotech to extend human lifespan through disease-targeted drug development.
Leiden-based BIMINI Biotech bags 3MBIMINI Biotech secured €3M to develop cancer therapeutics targeting WASp, addressing high relapse rates and poor outcomes in hematological cancers.
Gene-edited non-browning banana could cut food waste, scientists sayThe genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.
The most innovative companies in agriculture for 2025Innovative agriculture companies are focusing on sustainable practices to ensure future farming and food production.
EIB backs GreenLight Biosciences with 35M loan to replace traditional chemical pesticides using power of RNA - Silicon CanalsGreenLight Biosciences España secures €35M loan from EIB to advance RNA-based agricultural solutions.
Gene-edited non-browning banana could cut food waste, scientists sayThe genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.
The most innovative companies in agriculture for 2025Innovative agriculture companies are focusing on sustainable practices to ensure future farming and food production.
EIB backs GreenLight Biosciences with 35M loan to replace traditional chemical pesticides using power of RNA - Silicon CanalsGreenLight Biosciences España secures €35M loan from EIB to advance RNA-based agricultural solutions.
AI used to design a multi-step enzyme that can digest some plasticsThe enzyme design process improved significantly with PLACER screening, resulting in enzymes that could perform multiple reactions.
Scientists Horrified by "Mirror Life" That Could Wipe Out Biology As We Know ItMirror life technology poses existential risks that could endanger life on Earth, warranting immediate pause in research efforts.
Scientist reveals gruesome way mirror bacteria could take over bodyThe development of synthetic 'mirror bacteria' poses a significant risk to human health, potentially causing untreatable infections and blockages in the body.
AI used to design a multi-step enzyme that can digest some plasticsThe enzyme design process improved significantly with PLACER screening, resulting in enzymes that could perform multiple reactions.
Scientists Horrified by "Mirror Life" That Could Wipe Out Biology As We Know ItMirror life technology poses existential risks that could endanger life on Earth, warranting immediate pause in research efforts.
Scientist reveals gruesome way mirror bacteria could take over bodyThe development of synthetic 'mirror bacteria' poses a significant risk to human health, potentially causing untreatable infections and blockages in the body.
NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular SciencesEvo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunchAfynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.
NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular SciencesEvo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunchAfynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.
China Targets U.S. Biotech Firm in Broadening BlacklistChina escalates trade conflict with the U.S. by banning Illumina, signaling a robust response to tariffs.
UK & US-based healthtech startup Level Zero Health bags 6.63MLevel Zero Health has secured £5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.
Deepmind scientist raises $50m to use AI in protein design revolutionLatent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.
Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunchLatent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.
The Weekly Notable Startup Funding Report: 1/13/25Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.
Deepmind scientist raises $50m to use AI in protein design revolutionLatent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.
Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunchLatent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.
The Weekly Notable Startup Funding Report: 1/13/25Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.
Groundbreaking': scientists develop patch that can repair damaged heartsResearchers have developed implantable patches to treat heart failure using laboratory-grown heart muscle, offering new hope for patients.The patches made from reprogrammed blood cells are a breakthrough in biological transplants for heart conditions.
COVID-flu vaccine could provide broad, lasting protection | Cornell ChronicleA new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.
Male mosquitoes to be genetically engineered to poison females with semen in Australian researchGenetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.
Surgeons Transplant Engineered Pig Kidney Into Fourth PatientSuccessful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.
Male mosquitoes to be genetically engineered to poison females with semen in Australian researchGenetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.
Surgeons Transplant Engineered Pig Kidney Into Fourth PatientSuccessful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.
Leen Kawas on Resilience as Strategy: The Role of Female Leadership in Transformative ChangeWomen in leadership roles bring unique perspectives that enhance organizational transformation through adaptability and emotional intelligence.
Microbes can colonize space, produce drugs and create energy researchers are simulating their inner workings to harness howResearchers are digitally recreating microbial processes to more efficiently produce useful chemicals for various industries.
Bold red lipstick gets its color from crushed bugs. This biotech startup made a version that's insect-freeThe classic red color of lipstick traditionally comes from carmine, but a new biotech alternative has emerged without using insects.
The Centuries-Old, Incredibly Male Quest to Live ForeverThe longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.
Growth Hormone Therapy Market Set to Double by 2032 - Here's WhyThe growth hormone therapy market is rapidly expanding due to technological advancements and increased consumer demand.
The Centuries-Old, Incredibly Male Quest to Live ForeverThe longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.
Growth Hormone Therapy Market Set to Double by 2032 - Here's WhyThe growth hormone therapy market is rapidly expanding due to technological advancements and increased consumer demand.
These L.A. musicians investigated a medical mystery. What they discovered launched a new skincare lineA fungal infection inspired musicians Ann Marie Simpson-Einziger and Mike Einziger to pursue scientific discovery, resulting in the founding of a biotech beauty company.
Tetsuwan Scientific is making robotic AI scientists that can run experiments on their own | TechCrunchCristian Ponce and Theo Schäfer founded Tetsuwan Scientific to automate genetic engineering lab processes using modified robots and AI technology.
These L.A. musicians investigated a medical mystery. What they discovered launched a new skincare lineA fungal infection inspired musicians Ann Marie Simpson-Einziger and Mike Einziger to pursue scientific discovery, resulting in the founding of a biotech beauty company.
Tetsuwan Scientific is making robotic AI scientists that can run experiments on their own | TechCrunchCristian Ponce and Theo Schäfer founded Tetsuwan Scientific to automate genetic engineering lab processes using modified robots and AI technology.
US court upholds Theranos founder Elizabeth Holmes's convictionElizabeth Holmes's conviction for defrauding investors in Theranos is upheld by a U.S. court, rejecting her appeal against the ruling.
Federal Circuit (Again) Upholds Ravgen's Fetal DNA cffDNA PatentThe Federal Circuit upheld the validity of Ravgen's fetal DNA testing patent and clarified standing requirements for appealing IPR decisions.
An Entire Book Was Written in DNA-and You Can Buy It for $60DNA presents a highly compact solution for data storage, being at least 1,000 times more efficient than current hard drives.
Russia's security service says jailed American leaked biotechnology secretsEugene Spector sentenced to 15 years in Russia for leaking U.S.-sought biotechnology secrets, reflecting escalating tensions between the U.S. and Russia.
Man who defrauded biotech company of 840,000 jailed for over three yearsAdrianus Kees pled guilty to fraud that involved a scheme to extract funds from Ovagen under the guise of securing a loan.
Why is it so hard to rewrite a genome?Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.
Why "Living Intelligence" Is the Next Big ThingCompanies must recognize the convergence of AI, advanced sensors, and biotechnology to stay relevant in the evolving technological landscape.
This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunchNeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.
Loreal's latest device promises to help find out how well your skin responds to ingredients like retinolL'Oréal's Cell BioPrint analyzes skin to offer personalized anti-aging advice, leveraging proteomics technology.
Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in LabResearchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.
UK must do more to lead innovation in bio-tech sector, Lords committee saysThe UK must enhance its innovation in engineering biology to remain competitive on a global scale.
Why is it so hard to rewrite a genome?Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.
Why "Living Intelligence" Is the Next Big ThingCompanies must recognize the convergence of AI, advanced sensors, and biotechnology to stay relevant in the evolving technological landscape.
This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunchNeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.
Loreal's latest device promises to help find out how well your skin responds to ingredients like retinolL'Oréal's Cell BioPrint analyzes skin to offer personalized anti-aging advice, leveraging proteomics technology.
Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in LabResearchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.
UK must do more to lead innovation in bio-tech sector, Lords committee saysThe UK must enhance its innovation in engineering biology to remain competitive on a global scale.
Ramaswamy Has a High-Profile Perch and a Raft of Potential ConflictsRamaswamy's financial interests present potential conflicts as he influences federal policies.
Amsterdam-based biotech company uniQure sets this share price for 73M public offering: Know more - Silicon CanalsuniQure plans to raise $75M through a public offering amid promising progress in gene therapies for Huntington's disease.
The strange future of lab-grown meat involves quail, crocodile, and woolly mammothVow's quail parfait represents a radical shift in food technology with lab-grown meat, prioritizing sustainability and innovative production methods.
Scientists explore longevity drugs for dogs that could also extend human life'Dogs can significantly impact their owners' health; biotech advancements aim to extend healthy lifespans for both dogs and humans.
Amsterdam deep tech startups that raised 1M & more in 2024Deep tech companies in the Netherlands are thriving, with increased investments and significant growth despite challenges in scaling.
A Bionic Leg Controlled by the BrainAdvanced prosthetics leverage carbon fibre, technology, and biological engineering to enhance human capabilities significantly.
Patients are so sick and tired of waiting years for a transplant that they're signing up in droves to receive vital organs from pigsXenotransplantation offers potential solutions to human organ shortages through the genetic modification of animals.
Leiden-based biotech company VitroScan secures 1.9M from National Growth Fund's Biotech Booster program - Silicon CanalsVitroScan secures €1.9M funding to enhance chemotherapy response prediction for ovarian cancer patients, preparing for clinical application.Biotech Booster aims to commercialize biotechnology research through funding, mentorship, and collaboration.